Cardinal Health (CAH) Expected to Announce Quarterly Earnings on Thursday

Cardinal Health (NYSE:CAH) is projected to issue its Q2 2026 results before the market opens on Thursday, February 5th. Analysts expect the company to announce earnings of $2.31 per share and revenue of $64.8790 billion for the quarter. Interested persons can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, February 5, 2026 at 8:30 AM ET.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The company had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same quarter last year, the business posted $1.88 EPS. Cardinal Health’s revenue for the quarter was up 22.4% on a year-over-year basis. On average, analysts expect Cardinal Health to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Cardinal Health Stock Down 1.8%

Shares of CAH opened at $210.22 on Thursday. The stock has a market cap of $49.95 billion, a PE ratio of 31.71, a PEG ratio of 1.45 and a beta of 0.65. Cardinal Health has a 12-month low of $120.72 and a 12-month high of $215.48. The business has a 50-day simple moving average of $206.07 and a two-hundred day simple moving average of $177.30.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd were paid a $0.5107 dividend. The ex-dividend date of this dividend was Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio is currently 30.77%.

Analyst Upgrades and Downgrades

CAH has been the topic of several recent research reports. Mizuho set a $222.00 target price on shares of Cardinal Health in a research report on Monday, January 12th. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, January 21st. Robert W. Baird set a $250.00 price objective on shares of Cardinal Health in a research note on Wednesday, January 14th. UBS Group raised their target price on Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a research report on Friday, October 31st. Finally, Wells Fargo & Company lifted their target price on Cardinal Health from $221.00 to $237.00 and gave the stock an “overweight” rating in a report on Thursday, January 15th. Fourteen investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and an average price target of $221.07.

Institutional Trading of Cardinal Health

A number of institutional investors have recently bought and sold shares of the company. Wellington Management Group LLP lifted its stake in shares of Cardinal Health by 153.2% in the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after purchasing an additional 3,511,579 shares during the period. Worldquant Millennium Advisors LLC bought a new stake in Cardinal Health in the second quarter worth approximately $79,963,000. Invesco Ltd. lifted its stake in Cardinal Health by 14.7% in the third quarter. Invesco Ltd. now owns 3,483,207 shares of the company’s stock valued at $546,724,000 after buying an additional 445,425 shares during the period. Ameriprise Financial Inc. boosted its holdings in shares of Cardinal Health by 33.0% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,455,196 shares of the company’s stock worth $228,467,000 after buying an additional 360,725 shares in the last quarter. Finally, Man Group plc increased its stake in shares of Cardinal Health by 26.1% in the 3rd quarter. Man Group plc now owns 1,605,349 shares of the company’s stock valued at $251,976,000 after acquiring an additional 331,783 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.